DA
CELG

David Abrams’s Celgene Corp CELG Stock Holding History

David Abrams’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,752,869
Closed -$671M – 23
2019
Q3 		$671M Hold
6,752,869
– – 18.77% 1
2019
Q2 		$624M Hold
6,752,869
– – 16.96% 1
2019
Q1 		$637M Buy
+6,752,869
New +$591M 17.89% 1

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $341K AUM 32.64% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

David Abrams's CELG Position: Q4 2019 in Review

David Abrams sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,752,869 shares — an estimated $671M sold.

David Abrams first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $671M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • David Abrams reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • David Abrams sold 6,752,869 Celgene Corp shares in Q4 2019, an estimated $671M.
  • David Abrams first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • David Abrams's Celgene Corp position peaked at $671M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Abrams Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.